In the Drug Profile by Helio S Sader and Ronald N Jones, Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections published in the February 2007 issue of Expert Review of Anti-infective Therapy (Expert Rev. Anti Infect. Ther. 5[1], 29–33 [2007]), the following text was published:
Patients were randomized to receive 10 days of cefdinir 300 mg twice daily or cephalexin 250 mg daily.
The correct text is given below:
Patients were randomized to receive 10 days of cefdinir 300 mg twice daily or cephalexin 250 mg four-times daily.
The editors of Expert Review of Anti-infective Therapy would like to sincerely apologize for any inconvenience or confusion this may cause our readers.